The Binding of Agonists and Antagonists to Rat Lung Beta-Adrenergic Receptors as Investigated by Thermodynamics and Structure-activity Relationships

References

• Munoz-Raminez H., Haavik C. O., Ryan C. F. Temperature-dependent supersensitivity to isoprenaline in mouse atria. Eur. J. Pharmacol. 1973; 22: 43–46
   PubMed Web of Science ®Google Scholar
• Wöppel W., Trendelenburg U. Temperature dependent supersensitivity of isolated atria to catecholamines. Eur. J. Pharmacol. 1973; 23: 302–305
   PubMed Web of Science ®Google Scholar
• Broadley K. J., McNeill J. H. Dissociation constants (Ka) and relative efficacities of sympathomimetic amines in isolated atria during hypothermia-induced supersensitivity. Can. J. Phys. Pharmacol. 1983; 61: 572–580
   PubMed Web of Science ®Google Scholar
• Chess-Williams R. G., Broadley K. J., Duncan C. A fundamental temperature-dependent difference between beta-adrenoceptor agonists and antagonists. Life Sci. 1984; 35: 1091–1099
   PubMed Web of Science ®Google Scholar
• Weiland G. A., Minneman K. P., Molinoff P. B. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature 1979; 281: 114–117
   PubMed Web of Science ®Google Scholar
• Weiland G. A., Minneman K. P., Molinoff P. B. Thermodynamics of Agonist and Antagonist interactions with Mammalian beta-adrenergic receptors. Mol. Pharmacol. 1980; 18: 341–347
   PubMed Web of Science ®Google Scholar
• Pike L. J., Lefkowitz R. J. Agonist specific alterations in receptor binding affinity associated with solubilization of turkey erythrocyte membrane beta adrenergic receptors. Mol. Pharmacol. 1978; 14: 370–375
   PubMed Web of Science ®Google Scholar
• Insel P. A., Sanda M. J. Temperature-dependent changes in binding to beta-adrenergic receptors of intact S49 lymphoma cells. Implications for the state of the receptor that activates adenylate cyclase under physiological conditions. J. Biol. Chem. 1979; 254: 6554–6559
   PubMed Web of Science ®Google Scholar
• Woods P. B., Robinson M. L. An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents. J. Pharm. Pharmacol. 1981; 3: 172–173
   Google Scholar
• Jack D. B. Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists. Brit. J. Clin. Pharmacol. 1981; 11: 402–406
   PubMed Web of Science ®Google Scholar
• Dax E. M., Partilla J. S. Adrenergic ligand liposolubility in membranes. Direct Assessment in a beta-adrenergic binding system. Mol. Pharmacol. 1982; 22: 5–7
   PubMed Web of Science ®Google Scholar
• Kilpatrick G. J., El Tayar N., Van de Waterbeemd H., Jenner P., Testa B., Marsden C. D. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors. Mol. Pharmacol. 1986; 30: 226–234
   PubMed Web of Science ®Google Scholar
• Rugg E. L., Barnett D. B., Nahorski S. R. Coexistance of beta1 and beta2-adrenoceptors in mammalian lung: evidence from direct binding studies. Mol. Pharmacol. 1978; 14: 996–1005
   PubMed Web of Science ®Google Scholar
• Engel G., Hoyer D., Berthold R., Wagner H. (+) [125Iodo]cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea-pig. Naunyn-Schmied. Arch. Pharmacol. 1981; 317: 277–285
   PubMed Web of Science ®Google Scholar
• Hoyer D., Engel G., Berthold R. Binding characteristics of (+)-, (+)-, and (-)-[125Iodo]cyanopindolol to guinea pig left ventricle membranes. Naunyn-Schmied. Arch. Pharmacol. 1982; 318: 319–329
   PubMed Web of Science ®Google Scholar
• Cheng Y., Prussof W. H. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr N. J., Randall R. J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Zini R., Gault I., Ledewyn S., D'Athis Ph., Tillement J. P. Binding of propranolol and iodocyanopindolol to isolated cells, homogenates and plasma membranes of rat liver, lung, kidney and heart. Biochem. Pharmacol. 1983; 32: 3375–3380
   PubMed Web of Science ®Google Scholar
• Benet L. Z., Goyan J. E. Potentiometric determination of dissociation constants. J. Pharm. Sci. 1967; 56: 665–680
   PubMed Web of Science ®Google Scholar
• Leeson L. J., Brown M. Some observations on non logarithmic titration curves for the determination of dissociation constants and purity. J. Pharm. Sci. 1966; 55: 431–433
   PubMed Web of Science ®Google Scholar
• El Tayar N., Van de Waterbeemd H., Testa B. Lipophilicity measurements of protonated basic compounds by reversed phase high performance liquid chromatography. II Procedure for the determination of a lipophilic index measured by reversed-phase high performance liquid chromatography. J. Chromatogr. 1985; 320: 305–312
   Web of Science ®Google Scholar
• Hennion M. C., Picard C., Claude M. Influence of the number and length of alkyl chains on the chromatographic properties of hydrocarbonaceous bonded phases. J. Chromatogr. 1978; 166: 21–35
   Web of Science ®Google Scholar
• El Tayar N., Van de Waterbeemd H., Testa B. Lipophilicity measurements of protonated basic compounds by reversed phase high performance liquid chromatography. I-Relationship between capacity factors and the methanol concentration in methanol-water eluents. J. Chromatogr. 1985; 320: 293–304
   Web of Science ®Google Scholar
• Dunn W. J., III, Wold S. Relationship between chemical structure and biological activity modeled by SIMCA pattern recombination. Bioorg. Chem. 1980; 9: 505–523
   Web of Science ®Google Scholar
• Wishart D. Computer Centre. University College London, LondonUK, 19 Gordon Street WCIH OAH
   Google Scholar
• Kubinyi H., Kehrhahn O. H. Quantitative Structure-Activity Relationships. VI. Non-linear dependance of biological activity on hydrophobic character: Calculation procedures for the bilinear model. Arzneim-Forsch. 1978; 28: 598–601
   PubMed Web of Science ®Google Scholar
• Hayes J. S., Bowling N., Pollock G. D. Effects of beta adrenoceptor down-regulation on the cardiovascular responses to the stereoisomers of dobutamine. J. Pharmacol. Exp. Ther. 1985; 235: 58–65
   PubMed Web of Science ®Google Scholar
• Cruickshank J. M. The clinical importance of cardioselectivity and lipophilicity in beta blockers. Amer. J. Heart. 1980; 100: 160–178
   PubMed Web of Science ®Google Scholar
• Hansch C., Leo A. Substituent Constants for correlation Analysis in Chemistry and Biology. Wiley, New-York 1979
   Google Scholar
• Hansch C., Leo A. Pomona College Medicinal Chemistry Project Log P Database. 1983, Issue 23
   Google Scholar
• Ruffolo R. R., Yaden E. L. Vascular effects of the stereoisomers of dobutamine. J. Pharmacol. Exp. Ther. 1983; 224: 46–50
   PubMed Web of Science ®Google Scholar
• Tomlinson E. Enthalpy-entropy compensation analysis of pharmaceutical and biological systems. Int. J. Pharmaceut. 1983; 13: 115–144
   Web of Science ®Google Scholar
• Main B. G. Structure-activity relationships in beta-adrenergic agents. Proceedings of the VIIIth International Symposium on Medicinal Chemistry. 1985, R. Dahlbom, J. L.G. Nilsson. Swedish Pharmaceutical Press, Stockholm, vol. 1: 41–56
   Google Scholar
• Timmermans P. B.M.W.M. Structure-activity-selectivity relationship in alpha-adrenoceptor agonists and antagonists. Proceedings of the VIIIth International Symposium on Medicinal Chemistry. 1985, R. Dahlbom, J. L.G. Nilsson. Swedish Pharmaceutical Press, Stockholm, vol 1: 69–82
   Google Scholar
• Reynolds R. C., Hardman H. F. The effect of pH changes and ionization on the action of epinephrine upon isolated rabbit ileum. Eur. J. Pharmacol. 1979; 20: 249–255
   Google Scholar
• Newton D. W., Kluza R. B. pKa values of medicinal compounds in pharmacy practice. Drug. Intel. Clin. Pharm. 1978; 12: 546–554
   Google Scholar